B, M., F, S., J, O., J, M., E, V., GA, A., . . . JA, A. (2024). Safety and Immunogenicity of Accelerated Heterologous 2-Dose Ebola Vaccine Regimens in Adults With and Without HIV in Africa. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 79(4), 888. https://doi.org/10.1093/cid/ciae215
Chicago Style (17th ed.) CitationB, Mwesigwa, et al. "Safety and Immunogenicity of Accelerated Heterologous 2-Dose Ebola Vaccine Regimens in Adults With and Without HIV in Africa." Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America 79, no. 4 (2024): 888. https://doi.org/10.1093/cid/ciae215.
MLA (9th ed.) CitationB, Mwesigwa, et al. "Safety and Immunogenicity of Accelerated Heterologous 2-Dose Ebola Vaccine Regimens in Adults With and Without HIV in Africa." Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America, vol. 79, no. 4, 2024, p. 888, https://doi.org/10.1093/cid/ciae215.
